Cited by 1,817PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase SignalingMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Open access

Mendoza, Michelle C., Er, E. Emrah, Blenis, John·2011·Trends in Biochemical Sciences

DOI 10.1016/j.tibs.2011.03.006PMC PMC3112285

Open this paper in CoChat — free account

Abstract

The Ras-extracellular signal-regulated kinase (Ras-ERK) and phosphatidylinositol 3-kinase-mammalian target of rapamycin (PI3K-mTOR) signaling pathways are the chief mechanisms for controlling cell survival, differentiation, proliferation, metabolism, and motility in response to extracellular cues. Components of these pathways were among the first to be discovered when scientists began cloning proto-oncogenes and purifying cellular kinase activities in the 1980s. Ras-ERK and PI3K-mTOR were originally modeled as linear signaling conduits activated by different stimuli, yet even early experiments hinted that they might intersect to regulate each other and co-regulate downstream functions. The extent of this cross-talk and its significance in cancer therapeutics are now becoming clear.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.tibs.2011.03.006

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,578
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,244
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent Mechanisms
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,908
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460

Flagged first, then by citations

Show all 103 references

2 of the 103 references couldn’t be matched to a known paper.

Sorted by citations

Items 601–700 of 1,004

Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7–H4 expression through the MEK/ERK signaling pathway
Zhao, Z., Zhang, N., Li, A., Zhou, B., Chen, Y., Chen, S., Huang, M., Wu, F., & Zhang, L. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.04.013 · Cited by 31
The role of oxidized ATM in the regulation of oxidative stress-induced energy metabolism reprogramming of CAFs
Tang, S., Yang, L., Tang, X., & Liu, M. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.028 · Cited by 33
Dopaminergic tone regulates transient potassium current maximal conductance through a translational mechanism requiring D1Rs, cAMP/PKA, Erk and mTOR
Rodgers, E. W., Krenz, W. C., Jiang, X., Li, L., & Baro, D. J. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-143 · Cited by 34
Exploring Novel Therapeutic Opportunities for Glioblastoma Using Patient-Derived Cell Cultures
Ciechomska, I. A., Wojnicki, K., Wojtaś, B., Szadkowska, P., Poleszak, K., Kaza, B., Jaskuła, K., Dawidczyk, W., Czepko, R. A., Banach, M., et al. (2023) · Cancers · doi:10.3390/cancers15051562 · Cited by 30
Mitogen signaling strength and duration can control cell cycle decisions
Nussinov, R., Zhang, W., Liu, Y., & Jang, H. (2024) · Science Advances · doi:10.1126/sciadv.adm9211 · Cited by 33
Unravelling molecular mechanism of oral squamous cell carcinoma and genetic landscape: an insight into disease complexity, available therapies, and future considerations
Shebbo, S., Alateyah, N., Yassin, E., Mahmoud, D. E. S., Tamimi, F., Anweigi, L. M., Elhissi, A. M. A., Abou-Saleh, H., Elrayess, M. A., & Agouni, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1626243 · Cited by 41
Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models
Schrauwen, S., Depreeuw, J., Coenegrachts, L., Hermans, E., Lambrechts, D., & Amant, F. C. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.04.028 · Cited by 32
Exosomal miRs in Lung Cancer: A Mathematical Model
Lai, X., & Friedman, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167706 · Cited by 34
Involvement of extracellular signal-regulated kinase (ERK) in the short and long-lasting antidepressant-like activity of NMDA receptor antagonists (zinc and Ro 25-6981) in the forced swim test in rats
Pochwat, B., Rafało-Ulińska, A., Domin, H., Misztak, P., Nowak, G., & Szewczyk, B. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.006 · Cited by 30
PTEN loss and activation of K‐RAS and β‐catenin cooperate to accelerate prostate tumourigenesis
Jefferies, M. T., Cox, A. C., Shorning, B. Y., Méniel, V. S., Griffiths, D. F. R., Kynaston, H., Smalley, M. J., & Clarke, A. R. (2017) · The Journal of Pathology · doi:10.1002/path.4977 · Cited by 33
The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells
Tsuboi, M., Taniuchi, K., Shimizu, T., Saito, M., & Saibara, T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772780 · Cited by 31
Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity
Li, F., Shang, X.-K., Du, X., & Chen, S. (2018) · Current Medical Science · doi:10.1007/s11596-018-1851-z · Cited by 31
RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway
Lu, P., Chen, J., Yan, L., Yang, L., Zhang, L., Dai, J., Hao, Z., Bai, T., Xi, Y., Li, Y., et al. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1529117 · Cited by 31
Upstream regulators of phosphoinositide 3‐kinase and their role in diseases
Wang, D., Zhou, W., Chen, J., & Wei, W. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28215 · Cited by 31
Hypoxia-Associated Factor (HAF) Mediates Neurofibromin Ubiquitination and Degradation Leading to Ras–ERK Pathway Activation in Hypoxia
Green, Y. S., Sargis, T., Reichert, E. C., Rudasi, E., Fuja, D. G., Jonasch, E. W., & Koh, M. Y. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1080 · Cited by 30
Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells
Noyan, S., Gürdal, H., & Dedeoğlu, B. G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215894 · Cited by 32
Short-term cellular memory tunes the signaling responses of the chemokine receptor CXCR4
Spinosa, P. C., Humphries, B. A., Lewin Mejia, D., Buschhaus, J. M., Linderman, J. J., Luker, G. D., & Luker, K. E. (2019) · Science Signaling · doi:10.1126/scisignal.aaw4204 · Cited by 31
An evaluation of fulvestrant for the treatment of metastatic breast cancer
Soleja, M., Raj, G. V., & Unni, N. G. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1651293 · Cited by 29
Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma
Bresin, A., Cristofoletti, C., Caprini, E., Cantonetti, M., Monopoli, A., Russo, G., & Narducci, M. G. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.08.454 · Cited by 31
Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
Scully, T., KASE, N. G., Gallagher, E. J., & LeRoith, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-97327-y · Cited by 29
RETRACTED ARTICLE: N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways
Xiao, K., Liu, P., Yan, P., Liu, Y., Song, L., Liu, Y., & Xie, L. (2021) · Bioengineered · doi:10.1080/21655979.2021.1999550 · Cited by 31
Retracted
B7–H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression
Lu, Y., Wu, F., Cao, Q., Sun, Y., Huang, M., Xiao, J., Zhou, B., & Zhang, L. (2021) · Oncogene · doi:10.1038/s41388-021-02124-6 · Cited by 31
Control of gastruloid patterning and morphogenesis by the Erk and Akt signaling pathways
Underhill, E. J., & Toettcher, J. E. (2023) · Development · doi:10.1242/dev.201663 · Cited by 31
Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1
Chang, H.-H., Young, S. H., Sinnett‐Smith, J. W., Chou, C. E. N., Moro, A., Hertzer, K. M., Hines, O. J., Rozengurt, E., & Eibl, G. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00417.2014 · Cited by 31
Patient-derived iPSCs show premature neural differentiation and neuron type-specific phenotypes relevant to neurodevelopment
Yeh, E., Dao, D. Q., Wu, Z. Y., Kandalam, S., Camacho, F. M., Tom, C., Zhang, W., Krencik, R., Rauen, K. A., Ullian, E. M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.238 · Cited by 32
New insights into transcription elongation control of HIV-1 latency and rebound
Mbonye, U. R., Kizito, F., & Karn, J. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.11.003 · Cited by 28
Augmented Pentose Phosphate Pathway Plays Critical Roles in Colorectal Carcinomas
Shibuya, N., Inoue, K.-I., Tanaka, G., Akimoto, K., & Kubota, K. (2015) · Oncology · doi:10.1159/000369905 · Cited by 30
17β-Estradiol enhances sulforaphane cardioprotection against oxidative stress
Angeloni, C., Teti, G., Barbalace, M. C., Malaguti, M., Falconi, M., & Hrelia, S. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.12.017 · Cited by 30
Global Phosphoproteomic Analysis of Insulin/Akt/mTORC1/S6K Signaling in Rat Hepatocytes
Zhang, Y., Zhang, Y., & Yu, Y. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00140 · Cited by 28
Loss of Igf2 Gene Imprinting in Murine Prostate Promotes Widespread Neoplastic Growth
Damaschke, N., Yang, B., Bhusari, S. S., Avilla, M. N., Zhong, W., Blute, M. L., Huang, W., & Jarrard, D. F. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3089 · Cited by 29
Intratumor MAPK and PI3K signaling pathway heterogeneity in glioblastoma tissue correlates with CREB signaling and distinct target gene signatures
Daniel, P. M., Filiz, G., Tymms, M. J., Ramsay, R. G., Kaye, A. H., Stylli, S. S., & Mantamadiotis, T. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.05.009 · Cited by 30
Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature
Rahane, C. S., Kutzner, A., & Heese, K. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.10.005 · Cited by 30
6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells
Venturelli, S., Niessner, H., Sinnberg, T. W., Berger, A., Burkard, M., Urmann, C., Donaubauer, K., Böcker, A., Leischner, C., Riepl, H., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495275 · Cited by 32
Modeling Mammalian Commitment to the Neural Lineage Using Embryos and Embryonic Stem Cells
Shparberg, R. A., Glover, H. J., & Morris, M. B. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00705 · Cited by 39
Apelin enhances IL-1β expression in human synovial fibroblasts by inhibiting miR-144-3p through the PI3K and ERK pathways
Chang, T., Wang, Y., Kuo, S., Wang, S., Tsai, C., Fong, Y., Wu, N., Liu, S., & Tang, C. (2020) · Aging · doi:10.18632/aging.103195 · Cited by 30
Signaling pathways downstream to receptor tyrosine kinases: targets for cancer treatment
Cordover, E., & Minden, A. (2020) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2020.101 · Cited by 31
CISD2 plays a role in age-related diseases and cancer
Liao, H.-Y., Liao, B., & Zhang, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111472 · Cited by 33
Neuroprotective effect of Lactobacillus plantarum DP189 on MPTP-induced Parkinson's disease model mice
Wang, L., Li, S., Jiang, Y., Zhao, Z., Shen, Y., Zhang, J., & Zhao, L. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104635 · Cited by 32
An effective cytokine combination for ex vivo expansion of porcine muscle stem cells
Lei, Q., Li, M., Du, G., Zhou, J., & Guan, X. (2022) · Food Bioscience · doi:10.1016/j.fbio.2022.101571 · Cited by 30
Interactions of melatonin with various signaling pathways: implications for cancer therapy
Mihanfar, A., Yousefi, B., Azizzadeh, B., & Majidinia, M. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02825-2 · Cited by 30
Postconditioning Protects Against Reperfusion Injury in Hypertensive Dilated Cardiomyopathy by Activating MEK/ERK1/2 Signaling
Hernández‐Reséndiz, S., Roldán, F., Correa, F., Abundis, E. M., Osorio-Valencia, G., Ruíz-de-Jesús, O., Alexánderson, E., Vigueras, R. M., Franco, M., & Zazueta, C. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.01.003 · Cited by 30
Unraveling Growth Factor Signaling and Cell Cycle Progression in Individual Fibroblasts
Gross, S. M., & Rotwein, P. S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.734194 · Cited by 30
Disinhibition of the extracellular-signal-regulated kinase restores the amplification of circadian rhythms by lithium in cells from bipolar disorder patients
McCarthy, M. J., Wei, H., Landgraf, D., Roux, M. J. L., & Welsh, D. K. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.05.003 · Cited by 31
Aberrant neuronal activity-induced signaling and gene expression in a mouse model of RASopathy
Altmüller, F., Pothula, S., Annamneedi, A., Nakhaei‐Rad, S., Montenegro‐Venegas, C., Pina-Fernández, E., Marini, C., Santos, M., Schanze, D., Montag, D., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006684 · Cited by 30
Recent advances in uveal melanoma treatment
Álvarez‐Rodríguez, B., Latorre, A., Posch, C., & Somoza, Á. (2017) · Medicinal Research Reviews · doi:10.1002/med.21460 · Cited by 30
EGF regulation of proximal tubule cell proliferation and VEGF-A secretion
Zepeda‐Orozco, D., Wen, H., Hamilton, B. A., Raikwar, N. S., & Thomas, C. P. (2017) · Physiological Reports · doi:10.14814/phy2.13453 · Cited by 30
Crucial Roles of 5-HT and 5-HT2 Receptor in Diabetes-Related Lipid Accumulation and Pro-Inflammatory Cytokine Generation in Hepatocytes
Fu, J., Li, C., Zhang, G., Tong, X., Zhang, H., Ding, J., Ma, Y., Cheng, R., Hou, S., An, S., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492656 · Cited by 31
Germline mutations in a G protein identify signaling cross-talk in T cells
Ham, H., Jing, H., Lamborn, I. T., Kober, M. M., Koval, A., Berchiche, Y. A., Anderson, D. E., Druey, K. M., Mandl, J. N., Isidor, B., et al. (2024) · Science · doi:10.1126/science.add8947 · Cited by 31
Killing Me Softly—Future Challenges in Apoptosis Research
Westhoff, M., Brühl, O., Nonnenmacher, L., Karpel‐Massler, G., & Debatin, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033746 · Cited by 29
PRL-3 activates mTORC1 in Cancer Progression
Ye, Z., Al-Aidaroos, A. Q., Park, J. E., Yuen, H. F., Zhang, S., Gupta, A. K., Lin, Y., Shen, H., & Zeng, Q. (2015) · Scientific Reports · doi:10.1038/srep17046 · Cited by 29
Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation
Bourke, L., McCormick, J., Taylor, V., Pericleous, C., Blanchet, B., Costedoat-Chalumeau, N., Stuckey, D. J., Lythgoe, M. F., Stephanou, A., & Ioannou, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143771 · Cited by 29
mTOR inhibitors in urinary bladder cancer
Pinto‐Leite, R., Arantes‐Rodrigues, R., Sousa, N., Oliveira, P. A., & Santos, L. L. (2016) · Tumor Biology · doi:10.1007/s13277-016-5083-1 · Cited by 30
Chloroquine Suppresses the Development of Hypertension in Spontaneously Hypertensive Rats
McCarthy, C. G., Wenceslau, C. F., Goulopoulou, S., Baban, B., Matsumoto, T., & Webb, R. C. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw113 · Cited by 29
Transcription factors as critical players in melanoma invasiveness, drug resistance, and opportunities for therapeutic drug development
Cohen-Solal, K., Kaufman, H. L., & Lasfar, A. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12666 · Cited by 30
Dual Targeting of Y-Box Binding Protein-1 and Akt Inhibits Proliferation and Enhances the Chemosensitivity of Colorectal Cancer Cells
Maier, E., Attenberger, F., Tiwari, A., Lettau, K., Rebholz, S., Fehrenbacher, B., Schaller, M., Gani, C., & Toulany, M. (2019) · Cancers · doi:10.3390/cancers11040562 · Cited by 29
Blockade of AXL activation overcomes acquired resistance to EGFR tyrosine kinase inhibition in non-small cell lung cancer
Wang, F., Liu, X., Bartholdy, B., Cheng, H., & Halmos, B. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.09.61 · Cited by 28
Transplantation of 3D bio-printed cardiac mesh improves cardiac function and vessel formation via ANGPT1/Tie2 pathway in rats with acute myocardial infarction
Kim, K.-S., Joo, H. J., Choi, S., Kim, J.-H., Park, C., Song, M.-H., Noh, J.-M., Cha, J., Hong, S. J., Ahn, T. H., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/ac1e78 · Cited by 29
Paclitaxel Impedes EGFR-mutated PC9 Cell GrowthviaReactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression
Mohiuddin, M., & Kasahara, K. (2021) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20287 · Cited by 31
Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72
Ham, Y., & Mahoney, S. J. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.02.016 · Cited by 29
Anticarcinogenic Effects of the Ethanolic Extract of Salix aegyptiaca in Colon Cancer Cells: Involvement of Akt/PKB and MAPK Pathways
Enayat, S., Ceyhan, M. Ş., Başaran, A. A., Gürsel, M., & Banerjee, S. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.850966 · Cited by 29
The renewed battle against RAS-mutant cancers
Zhang, F., & Cheong, J. K. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2155-8 · Cited by 30
MAT2B promotes adipogenesis by modulating SAMe levels and activating AKT/ERK pathway during porcine intramuscular preadipocyte differentiation
Zhao, C., Chen, X., Wu, W., Wang, W., Pang, W., & Yang, G. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.02.019 · Cited by 29
Role of PI4K and PI3K-AKT in ERK1/2 activation by GnRH in the pituitary gonadotropes
Bar-Lev, T. H., Harris, D., Tomić, M., Stojilković, S. S., Blumenfeld, Z., Brown, P., Seger, R., & Naor, Z. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.07.029 · Cited by 29
Zebrafish model of posttraumatic epilepsy.
Cho, S., Park, E., Telliyan, T., Baker, A., & Reid, A. Y. (2020) · Epilepsia · doi:10.1111/epi.16589 · Cited by 29
Oxidative stress is two‐sided in the treatment of acute myeloid leukemia
Fan, C., Yang, X., Yan, L., & Shi, Z. (2024) · Cancer Medicine · doi:10.1002/cam4.6806 · Cited by 27
Radiogenomics and machine learning predict oncogenic signaling pathways in glioblastoma
Ahanger, A. B., Aalam, S. W., Masoodi, T., Shah, A., Khan, M. A., Bhat, A. A., Assad, A., Macha, M. A., & Bhat, M. R. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06101-5 · Cited by 33
An update on the cognitive impact of clinically-used hormone therapies in the female rat: Models, mazes, and mechanisms
Acosta, J. I., Hiroi, R., Camp, B. W., Talboom, J. S., & Bimonte‐Nelson, H. A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.016 · Cited by 30
Systemic inflammation inhibits serotonin receptor 2-induced phrenic motor facilitation upstream from BDNF/TrkB signaling
Agosto‐Marlin, I. M., Nichols, N. L., & Mitchell, G. S. (2018) · Journal of Neurophysiology · doi:10.1152/jn.00378.2017 · Cited by 28
Regulation of protein synthesis in porcine mammary epithelial cells by l-valine
Zhang, J., He, W., Yi, D., Zhao, D., Song, Z., Hou, Y., & Wu, G. (2019) · Amino Acids · doi:10.1007/s00726-019-02709-2 · Cited by 28
A Platform to Study the Effects of Electrical Stimulation on Immune Cell Activation During Wound Healing
Wang, K.-P., Parekh, U., Ting, J., Yamamoto, N. A. D., Zhu, J. H., Costantini, T. W., Arias, A. C., Eliceiri, B. P., & Ng, T. N. (2019) · Advanced Biosystems · doi:10.1002/adbi.201900106 · Cited by 28
The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumor cells
Lundsten, S., Spiegelberg, D., Stenerl�w, B., & Nestor, M. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4888 · Cited by 29
Inhibition of PI3K/AKT/mTOR and MAPK signaling pathways decreases progranulin expression in ovarian clear cell carcinoma (OCCC) cell line: a potential biomarker for therapy response to signaling pathway inhibitors
Perez-Juarez, C. E., Arechavaleta-Velasco, F., Zeferino-Toquero, M., Álvarez‐Arellano, L., Estrada-Moscoso, I., & Dı́az-Cueto, L. (2019) · Medical Oncology · doi:10.1007/s12032-019-1326-5 · Cited by 28
Critical Signaling Events in the Mechanoactivation of Human Mast Cells through p.C492Y-ADGRE2
Naranjo, A. N., Bandara, G., Bai, Y., Smelkinson, M. G., Tobío, A., Komarow, H. D., Boyden, S. E., Kastner, D. L., Metcalfe, D. D., & Olivera, A. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.03.936 · Cited by 28
Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma
Polini, B., Carpi, S., Doccini, S., Citi, V., Martelli, A., Feola, S., Santorelli, F. M., Cerullo, V., Romanini, A., & Nieri, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176183 · Cited by 30
The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways
Candido, S., Salemi, R., Piccinin, S., Falzone, L., & Libra, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030590 · Cited by 28
Dual blockade of EGFR and PI3K signaling pathways offers a therapeutic strategy for glioblastoma
Guo, T., Wu, C., Zhang, J., Yu, J., Li, G., Jiang, H., Zhang, X., Yu, R., & Liu, X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01400-0 · Cited by 28
K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas
Feng, W., Liu, Y., Bellail, A. C., Olson, J. J., Sun, S. Y., Lu, G., Ding, L., Yuan, C., Wang, G., & Hao, C. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.005 · Cited by 28
Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy
Kammerer‐Jacquet, S., Médane, S., Bensalah, K., Bernhard, J., Yacoub, M., Dupuis, F., Ravaud, A., Verhoest, G., Mathiéu, R., Peyronnet, B., et al. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0498-1 · Cited by 28
Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin
Poore, B., Yuan, M., Arnold, A., Price, A. C., Alt, J., Rubens, J. A., Slusher, B. S., Eberhart, C. G., & Raabe, E. H. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy150 · Cited by 28
Cytosolic phospholipase A 2 α regulates G 1 progression through modulating FOXO1 activity
Naini, S. M., Choukroun, G. J., Ryan, J. R., Hentschel, D. M., Shah, J. V., & Bonventre, J. V. (2015) · The FASEB Journal · doi:10.1096/fj.15-278416 · Cited by 27
Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma
Vallejo-Díaz, J., Olazabal-Morán, M., Cariaga-Martínez, A. E., Pajares, M. J., Flores, J. M., Pı́o, R., Montuenga, L. M., & Carrera, A. C. (2016) · Oncotarget · doi:10.18632/oncotarget.13195 · Cited by 27
Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities
Stires, H., Heckler, M. M., Fu, X., Zhao, L., Grasso, C. S., Quist, M. J., Lewis, J. A., Klimach, U., Zwart, A. L., Mahajan, A., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.024 · Cited by 28
Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling
Lin, C., Suen, K. M., Stainthorp, A. K., Wieteska, Ł., Biggs, G. S., Leitão, A., Montanari, C. A., & Ladbury, J. E. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.008 · Cited by 27
Midkine promotes articular chondrocyte proliferation through the MK-LRP1-nucleolin signaling pathway
Deng, Q., Yu, X., Deng, S., Ye, H., Zhang, Y., Han, W., Li, J., & Yu, Y. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109423 · Cited by 27
Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma
Wei, B., Hoover, S. B., Peer, C. J., Dwyer, J. E., Adissu, H. A., Shankarappa, P. S., Yang, H. H., Lee, M. Y., Peat, T. J., Figg, W. D., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0858 · Cited by 26
New bioactive 5-arylcarboximidamidopyrazolo[3,4-c]pyridines: Synthesis, cytotoxic activity, mechanistic investigation and structure-activity relationships
Papastathopoulos, A., Lougiakis, N., Kostakis, I. K., Marakos, P., Pouli, N., Pratsinis, H., & Kletsas, D. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113387 · Cited by 28
An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma
Zewdu, R., Mehrabad, E. M., Ingram, K., Fang, P., Gillis, K. L., Camolotto, S. A., Orstad, G., Jones, A. D., Mendoza, M. C., Spike, B. T., et al. (2021) · eLife · doi:10.7554/elife.66788 · Cited by 22
Self-citation
mTOR Activation Initiates Renal Cell Carcinoma Development by Coordinating ERK and p38MAPK
Wu, H., He, D. N., Biswas, S., Shafiquzzaman, M., Zhou, X., Charron, J., Wang, Y., Nayak, B. K., Habib, S. L., Liu, H., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3979 · Cited by 26
Molecular mechanisms of Shigella effector proteins: a common pathogen among diarrheic pediatric population
Nasser, A., Mosadegh, M., Azimi, T., & Shariati, A. (2022) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-022-00145-z · Cited by 29
Crosstalk between protein kinases AKT and ERK1/2 in human lung tumor-derived cell models
Stulpinas, A., Sereika, M., Vitkevičienė, A., Imbrasaitė, A., Krestnikova, N., & Kalvelytė, A. V. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1045521 · Cited by 28
Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
Li, H., Hu, P., Zou, Y., Yuan, L., Xu, Y., Zhang, X., Luo, X., & Zhang, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1071415 · Cited by 27
Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1/2 in lesion formation
Aw, W. Y., Cho, C., Wang, H., Cooper, A. H., Doherty, E. L., Rocco, D. J., Huang, S. A., Kubik, S. E., Whitworth, C. P., Armstrong, R. T., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade8939 · Cited by 28
An optogenetic-phosphoproteomic study reveals dynamic Akt1 signaling profiles in endothelial cells
Zhou, W., Li, W., Wang, S., Šalovská, B., Hu, Z., Tao, B., Di, Y., Punyamurtula, U., Turk, B. E., Sessa, W. C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39514-1 · Cited by 29
Comprehensive analysis of the ubiquitinome during oncogene-induced senescence in human fibroblasts
Bengsch, F., Tu, Z., Tang, H., Zhu, H., Speicher, D. W., & Zhang, R. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1026492 · Cited by 28
Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer
Song, W., Li, W., Li, L., Zhang, S., Xu, Y., Wen, X., Zhang, X., Tian, H., Li, A., Hu, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4350 · Cited by 28
Targeting the Mammalian Target of Rapamycin in Lung Cancer
Vicary, G. W., & Roman, J. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.08.014 · Cited by 27
Invariant Chain Complexes and Clusters as Platforms for MIF Signaling
Lindner, R. M. (2017) · Cells · doi:10.3390/cells6010006 · Cited by 27
Kinase-Centric Computational Drug Development
Kooistra, A. J., & Volkamer, A. (2017) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2017.08.001 · Cited by 27
Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma
Milosevic, Z. C., Banković, J., Dinić, J., Tsimplouli, C., Sereti, E., Dragoj, M., Paunović, V., Milovanović, Z., Stepanović, M., Tanić, N., et al. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0380-x · Cited by 27
LvRas and LvRap are both important for WSSV replication in Litopenaeus vannamei
Tseng, Y.-T., Kumar, R., & Wang, H. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.02.035 · Cited by 27

Authors: Mendoza, M. C., Er, E. E., & Blenis, J.
Affiliations: Harvard University (US)
Corresponding author: Blenis, John
ORCID: Mendoza, Michelle C.
Er, E. Emrah
Blenis, John
Venue: Trends in Biochemical Sciences
Publisher: Elsevier BV
Published: 2011-06
Volume: 36
Issue: 6
Pages: 320-328
ISSN: 0968-0004 (ISSN-L)
DOI: 10.1016/j.tibs.2011.03.006
PMC: PMC3112285
OpenAlex: W1998203489
Cited by: 1,817
References: 103
Citations by year: 2026: 112 · 2025: 96 · 2024: 122 · 2023: 133 · 2022: 127 · 2021: 163 · 2020: 166 · 2019: 164 · 2018: 144 · 2017: 158 · 2016: 123 · 2015: 100 · 2014: 92 · 2013: 55 · 2012: 49
FWCI: 5.82
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Biochemical Sciences (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: LAM Foundation
Susan G. Komen
National Cancer Institute (R37CA046595)
National Institute of General Medical Sciences (R01GM051405)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: Ras/ERK signaling pathway, signaling crosstalk, cell survival, cell proliferation, cell differentiation, cellular metabolism, cell motility, proto-oncogenes, cancer therapeutics
MeSH terms: Humans, Signal Transduction, ras Proteins, Extracellular Signal-Regulated MAP Kinases, Phosphatidylinositol 3-Kinase, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks